Survodutide 10mg – Orbitrex Peptides

Survodutide (also known as BI 456906) is an investigational dual agonist peptide that targets both the GLP-1 receptor and the glucagon receptor. This dual-pathway mechanism positions it as a next-generation metabolic research compound with potential relevance in studies on body-weight regulation, adiposity reduction, and metabolic homeostasis. Its combination of anorectic effects (from GLP-1 activity) and thermogenic/lipolytic actions (from glucagon activation) makes it a valuable tool for studying synergistic metabolic pathways that influence weight loss and liver health. For research use only. Refer to product certificate of analysis for batch-specific specifications. Batch SV101125 purity/net content/endotoxins/heavy metals analysis